Efficacy of a telephone-based intervention among patients with type-2 diabetes; a randomized controlled trial in pharmacy practice

International Journal of Clinical Pharmacy

Volumn 40, Issue 2, 2018, Pages 345-353

  Sarayani, Amir ^a,d   Mashayekhi, Mojgan ^b   Nosrati, Marzieh ^b   Jahangard Rafsanjani, Zahra ^b   Javadi, Mohammadreza ^a,b   Saadat, Navid ^c   Najafi, Sheyda ^b   Gholami, Kheirollah ^a,b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d UNIVERSITY OF FLORIDA   (United States)

Author keywords

Diabetes education; Diabetes Type 2; HbA1c; Iran; Medication adherence; Pharmacist; Self care; Telephone counseling

Indexed keywords

ACARBOSE; CHOLESTEROL; GLIBENCLAMIDE; GLICLAZIDE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; LIPID; LOW DENSITY LIPOPROTEIN; METFORMIN; PIOGLITAZONE; REPAGLINIDE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD GLUCOSE MONITORING; CHOLESTEROL BLOOD LEVEL; CLINICAL OUTCOME; CLINICAL PRACTICE; CONTROLLED STUDY; DIABETIC PATIENT; DIET THERAPY; DRUG INFORMATION; EXERCISE; FEMALE; FOLLOW UP; FOOT CARE; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MEDICATION COMPLIANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PATIENT EDUCATION; PHARMACEUTICAL CARE; PHARMACIST; PHARMACY; POPULATION RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SELF CARE; TELECONSULTATION; TRIACYLGLYCEROL BLOOD LEVEL; AGED; IRAN; MIDDLE AGED; PROFESSIONAL STANDARD; TELEPHONE; TREATMENT OUTCOME; TRENDS; UTILIZATION;

ADULT; AGED; COMMUNITY PHARMACY SERVICES; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; IRAN; MALE; MEDICATION ADHERENCE; MIDDLE AGED; PHARMACISTS; PROFESSIONAL ROLE; SELF CARE; TELEPHONE; TREATMENT OUTCOME;

EID: 85041923285     PISSN: 22107703     EISSN: 22107711     Source Type: Journal    
DOI: 10.1007/s11096-018-0593-0     Document Type: Article

References (40)

1. Ogurtsova K, da Rocha Fernandes JD, Huang Y, Linnenkamp U, Guariguata L, Cho NH, et al. IDF diabetes atlas: global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes Res Clin Pract. 2017;128:40–50.
2. Menke A, Rust KF, Fradkin J, Cheng YJ, Cowie CC. Associations between trends in race/ethnicity, aging, and body mass index with diabetes prevalence in the United States: a series of cross-sectional studies. Ann Intern Med. 2014;161(5):328–35.
3. Hu H, Hori A, Nishiura C, Sasaki N, Okazaki H, Nakagawa T, et al. Hba1c, blood pressure, and lipid control in people with diabetes: Japan epidemiology collaboration on occupational health study. PLoS ONE. 2016;11(7):e0159071.
4. Stark Casagrande S, Fradkin JE, Saydah SH, Rust KF, Cowie CC. The prevalence of meeting A1C, blood pressure, and LDL goals among people with diabetes, 1988-2010. Diabetes Care. 2013;36(8):2271–9.
5. Feldman BS, Cohen-Stavi CJ, Leibowitz M, Hoshen MB, Singer SR, Bitterman H, et al. Defining the role of medication adherence in poor glycemic control among a general adult population with diabetes. PLoS ONE. 2014;9(9):e108145.
6. Sarayani A, Jahangard-Rafsanjani Z, Hadjibabaie M, Ahmadvand A, Javadi M, Gholami K. A comprehensive review of adherence to diabetes and cardiovascular medications in Iran; implications for practice and research. J Diabetes Metab Disord. 2013;12(1):57.
7. Paduch A, Kuske S, Schiereck T, Droste S, Loerbroks A, Sørensen M, et al. Psychosocial barriers to healthcare use among individuals with diabetes mellitus: a systematic review. Prim Care Diabetes. 2017;11(6):495–514.
8. Singh K, Ranjani H, Rhodes E, Weber MB. International models of care that address the growing diabetes prevalence in developing countries. Curr Diab Rep. 2016;16(8):69.
9. Wubben DP, Vivian EM. Effects of pharmacist outpatient interventions on adults with diabetes mellitus: a systematic review. Pharmacotherapy. 2008;28(4):421–36.
10. Rothman R, Malone R, Bryant B, Horlen C, Pignone M. Pharmacist-led, primary care-based disease management improves hemoglobin A1c in high-risk patients with diabetes. Am J Med Qual. 2003;18(2):51–8.
11. Clifford RM, Davis WA, Batty KT, Davis TM. Effect of a pharmaceutical care program on vascular risk factors in type 2 diabetes: the Fremantle Diabetes Study. Diabetes Care. 2005;28(4):771–6.
12. Farsaei S, Sabzghabaee AM, Zargarzadeh AH, Amini M. Effect of pharmacist-led patient education on glycemic control of type 2 diabetics: a randomized controlled trial. J Res Med Sci. 2011;16(1):43–9.
13. Armor BL, Britton ML, Dennis VC, Letassy NA. A review of pharmacist contributions to diabetes care in the United States. J Pharm Pract. 2010;23(3):250–64.
14. Jahangard-Rafsanjani Z, Sarayani A, Nosrati M, Saadat N, Rashidian A, Hadjibabaie M, et al. Effect of a community pharmacist-delivered diabetes support program for patients receiving specialty medical care: a randomized controlled trial. Diabetes Educ. 2015;41(1):127–35.
15. Collins C, Limone BL, Scholle JM, Coleman CI. Effect of pharmacist intervention on glycemic control in diabetes. Diabetes Res Clin Pract. 2011;92(2):145–52.
16. Pande S, Hiller JE, Nkansah N, Bero L. The effect of pharmacist-provided non-dispensing services on patient outcomes, health service utilisation and costs in low- and middle-income countries. Cochrane Database Syst Rev. 2013;2:CD010398.
17. Angaran DM. Telemedicine and telepharmacy: current status and future implications. Am J Health Syst Pharm. 1999;56(14):1405–26.
18. Harris JE, Chen TC, Kim SB, Nguyen KL. Development of a pharmacist-managed, telephone-based tobacco-cessation clinic for veterans. Am J Health Syst Pharm. 2009;66(18):1610.
19. Hailey D, Roine R, Ohinmaa A. Systematic review of evidence for the benefits of telemedicine. J Telemed Telecare. 2002;8(suppl 1):1–7.
20. Whitten PS, Mair FS, Haycox A, May CR, Williams TL, Hellmich S. Systematic review of cost effectiveness studies of telemedicine interventions. BMJ. 2002;324(7351):1434–7.
21. Holtz B, Lauckner C. Diabetes management via mobile phones: a systematic review. Telemed J E Health. 2012;18(3):175–84.
22. Krishna S, Boren SA. Diabetes self-management care via cell phone: a systematic review. J Diabetes Sci Technol (Online). 2008;2(3):509–17.
23. Nesari M, Zakerimoghadam M, Rajab A, Bassampour S, Faghihzadeh S. Effect of telephone follow-up on adherence to a diabetes therapeutic regimen. Jpn J Nurs Sci. 2010;7(2):121–8.
24. Zolfaghari M, Mousavifar SA, Pedram S, Haghani H. The impact of nurse short message services and telephone follow-ups on diabetic adherence: which one is more effective? J Clin Nurs. 2012;21(13–14):1922–31.
25. Wu L, Forbes A, Griffiths P, Milligan P, While A. Telephone follow-up to improve glycaemic control in patients with Type 2 diabetes: systematic review and meta-analysis of controlled trials. Diabet Med. 2010;27(11):1217–25.
26. Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. J Clin Epidemiol. 2010;63(8):834–40.
27. Saheb Sharif-Askari F, Saheb Sharif-Askari N, Javadi M, Gholami K. Adverse drug reactions reported to the drug and poison information center of Tehran. Iran. PLoS One. 2017;12(9):e0185450.
28. Gholami K, Kamalinia G, Ahmadian Attari MM, Salamzadeh J. Three years evaluation of drug shortages from educational pharmacies in tehran. Iran J Pharm Res. 2012;11(2):565–72.
29. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10(5):348–54.
30. Toobert DJ, Hampson SE, Glasgow RE. The summary of diabetes self-care activities measure: results from 7 studies and a revised scale. Diabetes Care. 2000;23(7):943–50.
31. Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A, et al. Principles of good practice for the translation and cultural adaptation process for patient-reported outcomes (PRO) measures: report of the ispor task force for translation and cultural adaptation. Value Health. 2005;8(2):94–104.
32. Suksomboon N, Poolsup N, Nge YL. Impact of phone call intervention on glycemic control in diabetes patients: a systematic review and meta-analysis of randomized, controlled trials. PLoS ONE. 2014;9(2):e89207.
33. Krass I, Armour C, Mitchell B, Brillant M, Dienaar R, Hughes J, et al. The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med. 2007;24(6):677–83.
34. Fera T, Bluml BM, Ellis WM. Diabetes ten city challenge: final economic and clinical results. J Am Pharm Assoc. 2009;49(3):383–91.
35. American-Diabetes-Association. Standards of medical care in diabetes—2013. Diabetes Care. 2013;36(Suppl 1):S11–S66.
36. American-Diabetes-Association. 9. Cardiovascular disease and risk management. Diabetes Care. 2017;40(Supplement 1):S75–S87.
37. Asche C, LaFleur J, Conner C. A review of diabetes treatment adherence and the association with clinical and economic outcomes. Clin Ther. 2011;33(1):74–109.
38. Tricco AC, Ivers NM, Grimshaw JM, Moher D, Turner L, Galipeau J, et al. Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis. Lancet. 2012;379(9833):2252–61.
39. Piette JD, Weinberger M, Kraemer FB, McPhee SJ. Impact of automated calls with nurse follow-up on diabetes treatment outcomes in a department of veterans affairs health care system. Diabetes Care. 2001;24(2):202–8.
40. Miguel A, Hall A, Liu W, Garrett J, Ballew A, Yang TH, et al. Improving comprehensive medication review acceptance by using a standardized recruitment script: a randomized control trial. J Manag Care Spec Pharm. 2017;23(1):13–21.